Rank | Gene Set | Z-score |
---|---|---|
1 | surfactant homeostasis (GO:0043129) | 5.18009035 |
2 | phosphate ion transport (GO:0006817) | 4.98512803 |
3 | drug transmembrane transport (GO:0006855) | 4.81612869 |
4 | urate metabolic process (GO:0046415) | 4.59744228 |
5 | phosphate ion transmembrane transport (GO:0035435) | 4.49935040 |
6 | chemical homeostasis within a tissue (GO:0048875) | 4.01870231 |
7 | lysine catabolic process (GO:0006554) | 3.90004481 |
8 | lysine metabolic process (GO:0006553) | 3.90004481 |
9 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.88822409 |
10 | organic cation transport (GO:0015695) | 3.81427321 |
11 | drug transport (GO:0015893) | 3.78674136 |
12 | quaternary ammonium group transport (GO:0015697) | 3.63442528 |
13 | sodium ion export (GO:0071436) | 3.35954113 |
14 | metanephric nephron tubule development (GO:0072234) | 3.34393440 |
15 | metanephric tubule development (GO:0072170) | 3.34393440 |
16 | sodium-independent organic anion transport (GO:0043252) | 3.30238571 |
17 | response to mercury ion (GO:0046689) | 3.28896415 |
18 | excretion (GO:0007588) | 3.27125382 |
19 | cysteine metabolic process (GO:0006534) | 3.26295086 |
20 | metanephric nephron epithelium development (GO:0072243) | 3.23564291 |
21 | cellular extravasation (GO:0045123) | 3.21994699 |
22 | negative regulation of complement activation (GO:0045916) | 3.21982928 |
23 | detection of molecule of bacterial origin (GO:0032490) | 3.19248067 |
24 | cellular potassium ion homeostasis (GO:0030007) | 3.18223532 |
25 | growth hormone receptor signaling pathway (GO:0060396) | 3.17328667 |
26 | positive regulation by symbiont of host defense response (GO:0052509) | 3.16462005 |
27 | modulation by symbiont of host defense response (GO:0052031) | 3.16462005 |
28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.16462005 |
29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.16462005 |
30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.16462005 |
31 | modulation by symbiont of host immune response (GO:0052553) | 3.16462005 |
32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.16140580 |
33 | negative regulation of protein activation cascade (GO:2000258) | 3.13006512 |
34 | trivalent inorganic anion homeostasis (GO:0072506) | 3.10380681 |
35 | phosphate ion homeostasis (GO:0055062) | 3.10380681 |
36 | protein localization to endosome (GO:0036010) | 3.06155116 |
37 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.04710898 |
38 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.00071125 |
39 | pinocytosis (GO:0006907) | 2.99514680 |
40 | embryonic process involved in female pregnancy (GO:0060136) | 2.97518934 |
41 | response to laminar fluid shear stress (GO:0034616) | 2.95469805 |
42 | carnitine transport (GO:0015879) | 2.94910517 |
43 | amino-acid betaine transport (GO:0015838) | 2.94910517 |
44 | tricarboxylic acid metabolic process (GO:0072350) | 2.94055266 |
45 | exogenous drug catabolic process (GO:0042738) | 2.93836472 |
46 | aspartate family amino acid catabolic process (GO:0009068) | 2.93805192 |
47 | histone H3-K36 demethylation (GO:0070544) | 2.90826318 |
48 | metanephric epithelium development (GO:0072207) | 2.88961978 |
49 | glutathione biosynthetic process (GO:0006750) | 2.87110186 |
50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.84984643 |
51 | response to peptidoglycan (GO:0032494) | 2.82570881 |
52 | drug catabolic process (GO:0042737) | 2.82349592 |
53 | positive regulation of receptor recycling (GO:0001921) | 2.81320017 |
54 | cellular response to growth hormone stimulus (GO:0071378) | 2.80819674 |
55 | peptide catabolic process (GO:0043171) | 2.79697592 |
56 | negative regulation of humoral immune response (GO:0002921) | 2.79078105 |
57 | focal adhesion assembly (GO:0048041) | 2.78695241 |
58 | cell-substrate adherens junction assembly (GO:0007045) | 2.78695241 |
59 | nephron tubule development (GO:0072080) | 2.78049098 |
60 | renal absorption (GO:0070293) | 2.77886262 |
61 | hemidesmosome assembly (GO:0031581) | 2.75526833 |
62 | regulation of complement activation (GO:0030449) | 2.75300264 |
63 | mannose metabolic process (GO:0006013) | 2.75241802 |
64 | negative regulation of interleukin-8 production (GO:0032717) | 2.71852983 |
65 | detection of other organism (GO:0098543) | 2.71019540 |
66 | vitamin D metabolic process (GO:0042359) | 2.70573594 |
67 | basement membrane organization (GO:0071711) | 2.69787336 |
68 | negative regulation of myotube differentiation (GO:0010832) | 2.67943869 |
69 | short-chain fatty acid metabolic process (GO:0046459) | 2.67838870 |
70 | macrophage activation involved in immune response (GO:0002281) | 2.67759086 |
71 | detection of external biotic stimulus (GO:0098581) | 2.65667985 |
72 | regulation of protein activation cascade (GO:2000257) | 2.64449169 |
73 | response to muramyl dipeptide (GO:0032495) | 2.63899993 |
74 | toxin transport (GO:1901998) | 2.63789473 |
75 | adherens junction assembly (GO:0034333) | 2.63761976 |
76 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.62104414 |
77 | pattern specification involved in kidney development (GO:0061004) | 2.58038769 |
78 | hypotonic response (GO:0006971) | 2.57244514 |
79 | potassium ion import (GO:0010107) | 2.56805514 |
80 | cellular hyperosmotic response (GO:0071474) | 2.55705674 |
81 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.54389200 |
82 | regulation of apoptotic cell clearance (GO:2000425) | 2.53917640 |
83 | angiogenesis involved in wound healing (GO:0060055) | 2.53810630 |
84 | glyoxylate metabolic process (GO:0046487) | 2.50769468 |
85 | cellular sodium ion homeostasis (GO:0006883) | 2.49531106 |
86 | adhesion of symbiont to host cell (GO:0044650) | 2.49007215 |
87 | virion attachment to host cell (GO:0019062) | 2.49007215 |
88 | renal tubule development (GO:0061326) | 2.47425843 |
89 | positive regulation of osteoblast proliferation (GO:0033690) | 2.47151972 |
90 | cellular response to vitamin (GO:0071295) | 2.46903638 |
91 | potassium ion homeostasis (GO:0055075) | 2.45957231 |
92 | response to growth hormone (GO:0060416) | 2.45016659 |
93 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.44610685 |
94 | creatine metabolic process (GO:0006600) | 2.44547986 |
95 | regulation of necroptotic process (GO:0060544) | 2.44494768 |
96 | sodium ion homeostasis (GO:0055078) | 2.43492804 |
97 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.42431601 |
98 | detection of bacterium (GO:0016045) | 2.42386864 |
99 | regulation of gamma-delta T cell activation (GO:0046643) | 2.42214574 |
100 | membrane repolarization during action potential (GO:0086011) | 2.42189102 |
101 | cellular response to vitamin D (GO:0071305) | 2.41260808 |
102 | positive regulation of Rap GTPase activity (GO:0032854) | 2.41243214 |
103 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.40221347 |
104 | atrioventricular valve morphogenesis (GO:0003181) | 2.39678122 |
105 | detection of biotic stimulus (GO:0009595) | 2.39509285 |
106 | valine metabolic process (GO:0006573) | 2.39341077 |
107 | neutrophil activation involved in immune response (GO:0002283) | 2.39077781 |
108 | renal filtration (GO:0097205) | 2.38534388 |
109 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.34694193 |
110 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.33548539 |
111 | cell adhesion mediated by integrin (GO:0033627) | 2.33506865 |
112 | fatty acid beta-oxidation (GO:0006635) | 2.33041491 |
113 | regulation of leukocyte degranulation (GO:0043300) | 2.32913417 |
114 | positive regulation of phagocytosis (GO:0050766) | 2.32628120 |
115 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.32519327 |
116 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.32495492 |
117 | histone H3-K9 demethylation (GO:0033169) | 2.30027387 |
118 | myelin maintenance (GO:0043217) | 2.29738404 |
119 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.29345410 |
120 | regulation of cholesterol homeostasis (GO:2000188) | 2.28647959 |
121 | branched-chain amino acid metabolic process (GO:0009081) | 2.28391449 |
122 | 2-oxoglutarate metabolic process (GO:0006103) | 2.26541659 |
123 | nephron epithelium development (GO:0072009) | 2.25458207 |
124 | peptide biosynthetic process (GO:0043043) | 2.25448675 |
125 | negative regulation of cell killing (GO:0031342) | 2.25099878 |
126 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.25099878 |
127 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.24755797 |
128 | iron ion import (GO:0097286) | 2.23768255 |
129 | receptor catabolic process (GO:0032801) | 2.23199023 |
130 | collecting duct development (GO:0072044) | 2.21947604 |
131 | membrane repolarization (GO:0086009) | 2.21417894 |
132 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.21188889 |
133 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.20388176 |
134 | response to host (GO:0075136) | 2.20388176 |
135 | response to host defenses (GO:0052200) | 2.20388176 |
136 | epithelial cell-cell adhesion (GO:0090136) | 2.20357933 |
137 | paraxial mesoderm development (GO:0048339) | 2.20190976 |
138 | fibroblast migration (GO:0010761) | 2.20102174 |
139 | regulation of hippo signaling (GO:0035330) | 2.19774059 |
140 | macrophage activation (GO:0042116) | 2.19769910 |
141 | cell communication by electrical coupling (GO:0010644) | 2.19480283 |
142 | response to parathyroid hormone (GO:0071107) | 2.19172671 |
143 | histone lysine demethylation (GO:0070076) | 2.18980418 |
144 | plasma lipoprotein particle assembly (GO:0034377) | 2.18558036 |
145 | plasma membrane repair (GO:0001778) | 2.18104967 |
146 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.17913231 |
147 | cell-cell junction maintenance (GO:0045217) | 2.17248594 |
148 | germinal center formation (GO:0002467) | 2.17168613 |
149 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.16047463 |
150 | negative regulation of fatty acid transport (GO:2000192) | 2.15959876 |
151 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.15759131 |
152 | apoptotic cell clearance (GO:0043277) | 2.15383479 |
153 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.14964620 |
154 | cell communication involved in cardiac conduction (GO:0086065) | 2.14096714 |
155 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.13147493 |
156 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.13127568 |
157 | response to phenylpropanoid (GO:0080184) | 2.12115463 |
158 | cell-substrate junction assembly (GO:0007044) | 2.11172067 |
159 | fatty acid oxidation (GO:0019395) | 2.10619800 |
160 | cellular modified amino acid catabolic process (GO:0042219) | 2.10580446 |
161 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.10234928 |
162 | cellular response to reactive nitrogen species (GO:1902170) | 2.09627122 |
163 | regulation of ARF protein signal transduction (GO:0032012) | 2.09519764 |
164 | camera-type eye morphogenesis (GO:0048593) | 2.09456019 |
165 | relaxation of cardiac muscle (GO:0055119) | 2.09312934 |
166 | sodium ion transport (GO:0006814) | 2.09151352 |
167 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.08994442 |
168 | response to host immune response (GO:0052572) | 2.08171685 |
169 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.08171685 |
170 | glomerular filtration (GO:0003094) | 2.08044364 |
171 | nephron tubule formation (GO:0072079) | 2.07661763 |
172 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.07568736 |
173 | hormone catabolic process (GO:0042447) | 2.07453479 |
174 | acetyl-CoA metabolic process (GO:0006084) | 2.07407535 |
175 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.07293971 |
176 | lipid oxidation (GO:0034440) | 2.07207668 |
177 | phospholipid scrambling (GO:0017121) | 2.07150401 |
178 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.07094852 |
179 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.06953058 |
180 | protein-lipid complex assembly (GO:0065005) | 2.05609959 |
181 | lung lobe morphogenesis (GO:0060463) | 2.05608614 |
182 | stress fiber assembly (GO:0043149) | 2.05370760 |
183 | beta-amyloid metabolic process (GO:0050435) | 2.05339995 |
184 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.05156947 |
185 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.05154414 |
186 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.05142412 |
187 | semaphorin-plexin signaling pathway (GO:0071526) | 2.04765549 |
188 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.04013605 |
189 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.03943531 |
190 | histone demethylation (GO:0016577) | 2.03423245 |
191 | regulation of mast cell degranulation (GO:0043304) | 2.02942303 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.90357507 |
2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.89501954 |
3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.57522462 |
4 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.35403456 |
5 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.13148946 |
6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.11756753 |
7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08612837 |
8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.07217330 |
9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.97632300 |
10 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.97015651 |
11 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.96921504 |
12 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.96818008 |
13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.91566785 |
14 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.91059474 |
15 | MYC_22102868_ChIP-Seq_BL_Human | 1.90940290 |
16 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.90886527 |
17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87509278 |
18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.86209053 |
19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.83771820 |
20 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.82778285 |
21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82500933 |
22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.80443296 |
23 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.79539425 |
24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75842941 |
25 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75440697 |
26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.74921570 |
27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72465170 |
28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.71757872 |
29 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.69530815 |
30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.69304897 |
31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.68975668 |
32 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.68890680 |
33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.65725037 |
34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.61815402 |
35 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.59908132 |
36 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.59018286 |
37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57200219 |
38 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.57061830 |
39 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.54961615 |
40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54470629 |
41 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.53691339 |
42 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.52456086 |
43 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.49197411 |
44 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.48991893 |
45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.47458904 |
46 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46431232 |
47 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.45527280 |
48 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.44825548 |
49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44077068 |
50 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.41893456 |
51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41256525 |
52 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.40850363 |
53 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.40824576 |
54 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.40824576 |
55 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.39244068 |
56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38911302 |
57 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.38819096 |
58 | CJUN_26792858_Chip-Seq_BT549_Human | 1.38395769 |
59 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.37762591 |
60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37740603 |
61 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.37714541 |
62 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.36735211 |
63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.35980351 |
64 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35148421 |
65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35122506 |
66 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.35045614 |
67 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.35045614 |
68 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34818760 |
69 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.32856382 |
70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31968860 |
71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30935955 |
72 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.30902699 |
73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29903867 |
74 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29224285 |
75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28928749 |
76 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.28191866 |
77 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.27924094 |
78 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.26820495 |
79 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.26315310 |
80 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.26037704 |
81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.25880302 |
82 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.25779577 |
83 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25762051 |
84 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23467223 |
85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23430877 |
86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23430877 |
87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23412240 |
88 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.20827560 |
89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.20524279 |
90 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19959700 |
91 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19181547 |
92 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18555235 |
93 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18111315 |
94 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.17311234 |
95 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15709465 |
96 | MAF_26560356_Chip-Seq_TH1_Human | 1.13817337 |
97 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.13332385 |
98 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12288644 |
99 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11678924 |
100 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.11391837 |
101 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10925227 |
102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.10872244 |
103 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09254719 |
104 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.08821323 |
105 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08571171 |
106 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.07592569 |
107 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.07347667 |
108 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.05504172 |
109 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.05356724 |
110 | GATA2_19941826_ChIP-Seq_K562_Human | 1.05059580 |
111 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04330419 |
112 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.04233256 |
113 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03841703 |
114 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.03724279 |
115 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.02829946 |
116 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.02552204 |
117 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01769831 |
118 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.00878225 |
119 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.00565869 |
120 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.00134981 |
121 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.00046568 |
122 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99719356 |
123 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99380839 |
124 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.98503391 |
125 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98280974 |
126 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97154565 |
127 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96979751 |
128 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96529593 |
129 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95750171 |
130 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95259386 |
131 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95259386 |
132 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94812687 |
133 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.94562177 |
134 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.94071669 |
135 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.93461976 |
136 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93185218 |
137 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.93055596 |
138 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.92992611 |
139 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92797131 |
140 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.92789175 |
141 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.91183947 |
142 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90831673 |
143 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90595929 |
144 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.90332337 |
145 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.88416355 |
146 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87703946 |
147 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86961764 |
148 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.86466087 |
149 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.86296209 |
150 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85999479 |
151 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.85657184 |
152 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83440623 |
153 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83329884 |
154 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83121222 |
155 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.82994650 |
156 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82614862 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001958_emphysema | 4.43303922 |
2 | MP0004043_abnormal_pH_regulation | 3.80519114 |
3 | MP0002138_abnormal_hepatobiliary_system | 2.99214064 |
4 | MP0005360_urolithiasis | 2.94038605 |
5 | MP0005451_abnormal_body_composition | 2.83714933 |
6 | MP0005076_abnormal_cell_differentiation | 2.65857724 |
7 | MP0001765_abnormal_ion_homeostasis | 2.43614153 |
8 | MP0003303_peritoneal_inflammation | 2.42601010 |
9 | MP0008438_abnormal_cutaneous_collagen | 2.41327253 |
10 | MP0004782_abnormal_surfactant_physiolog | 2.35458196 |
11 | MP0005377_hearing/vestibular/ear_phenot | 2.34928498 |
12 | MP0003878_abnormal_ear_physiology | 2.34928498 |
13 | MP0004019_abnormal_vitamin_homeostasis | 2.33504147 |
14 | MP0005409_darkened_coat_color | 2.23268755 |
15 | MP0003724_increased_susceptibility_to | 2.18810381 |
16 | MP0003828_pulmonary_edema | 2.17635780 |
17 | MP0010234_abnormal_vibrissa_follicle | 2.16707296 |
18 | MP0004272_abnormal_basement_membrane | 2.16595350 |
19 | MP0005332_abnormal_amino_acid | 2.15823615 |
20 | MP0009643_abnormal_urine_homeostasis | 2.11989435 |
21 | MP0005058_abnormal_lysosome_morphology | 2.11506443 |
22 | MP0008260_abnormal_autophagy | 2.08292717 |
23 | MP0003436_decreased_susceptibility_to | 2.07051436 |
24 | MP0003705_abnormal_hypodermis_morpholog | 2.03881001 |
25 | MP0003300_gastrointestinal_ulcer | 2.00962472 |
26 | MP0004885_abnormal_endolymph | 1.95397730 |
27 | MP0005275_abnormal_skin_tensile | 1.86437406 |
28 | MP0001756_abnormal_urination | 1.81143359 |
29 | MP0003183_abnormal_peptide_metabolism | 1.79836535 |
30 | MP0005623_abnormal_meninges_morphology | 1.73660744 |
31 | MP0004084_abnormal_cardiac_muscle | 1.67350356 |
32 | MP0002419_abnormal_innate_immunity | 1.65780720 |
33 | MP0001851_eye_inflammation | 1.64225201 |
34 | MP0002136_abnormal_kidney_physiology | 1.63594526 |
35 | MP0003045_fibrosis | 1.62037669 |
36 | MP0009278_abnormal_bone_marrow | 1.61084282 |
37 | MP0002877_abnormal_melanocyte_morpholog | 1.60523632 |
38 | MP0002998_abnormal_bone_remodeling | 1.56690406 |
39 | MP0003566_abnormal_cell_adhesion | 1.56329287 |
40 | MP0001177_atelectasis | 1.55196161 |
41 | MP0010352_gastrointestinal_tract_polyps | 1.54473239 |
42 | MP0002168_other_aberrant_phenotype | 1.54374313 |
43 | MP0002295_abnormal_pulmonary_circulatio | 1.51996085 |
44 | MP0003195_calcinosis | 1.49091070 |
45 | MP0004858_abnormal_nervous_system | 1.49082226 |
46 | MP0003453_abnormal_keratinocyte_physiol | 1.47714384 |
47 | MP0002396_abnormal_hematopoietic_system | 1.46367300 |
48 | MP0001915_intracranial_hemorrhage | 1.43548239 |
49 | MP0009780_abnormal_chondrocyte_physiolo | 1.42583076 |
50 | MP0010630_abnormal_cardiac_muscle | 1.41938975 |
51 | MP0003950_abnormal_plasma_membrane | 1.39214733 |
52 | MP0008961_abnormal_basal_metabolism | 1.39099983 |
53 | MP0000534_abnormal_ureter_morphology | 1.38043760 |
54 | MP0003252_abnormal_bile_duct | 1.37916619 |
55 | MP0004947_skin_inflammation | 1.37853478 |
56 | MP0000537_abnormal_urethra_morphology | 1.36914393 |
57 | MP0004036_abnormal_muscle_relaxation | 1.36903615 |
58 | MP0005464_abnormal_platelet_physiology | 1.36108016 |
59 | MP0010678_abnormal_skin_adnexa | 1.33993898 |
60 | MP0002896_abnormal_bone_mineralization | 1.31931736 |
61 | MP0005636_abnormal_mineral_homeostasis | 1.30882055 |
62 | MP0005023_abnormal_wound_healing | 1.28859120 |
63 | MP0003329_amyloid_beta_deposits | 1.26559727 |
64 | MP0000751_myopathy | 1.25818805 |
65 | MP0002139_abnormal_hepatobiliary_system | 1.25695972 |
66 | MP0009384_cardiac_valve_regurgitation | 1.23322220 |
67 | MP0005388_respiratory_system_phenotype | 1.22064096 |
68 | MP0002133_abnormal_respiratory_system | 1.22064096 |
69 | MP0010368_abnormal_lymphatic_system | 1.20551866 |
70 | MP0000767_abnormal_smooth_muscle | 1.16447386 |
71 | MP0008775_abnormal_heart_ventricle | 1.14733752 |
72 | MP0005025_abnormal_response_to | 1.14447477 |
73 | MP0005164_abnormal_response_to | 1.11739928 |
74 | MP0002925_abnormal_cardiovascular_devel | 1.11451538 |
75 | MP0002405_respiratory_system_inflammati | 1.11300450 |
76 | MP0008004_abnormal_stomach_pH | 1.10810865 |
77 | MP0000920_abnormal_myelination | 1.10610023 |
78 | MP0002796_impaired_skin_barrier | 1.09858409 |
79 | MP0005666_abnormal_adipose_tissue | 1.08986403 |
80 | MP0004883_abnormal_blood_vessel | 1.07127391 |
81 | MP0000858_altered_metastatic_potential | 1.07112124 |
82 | MP0001299_abnormal_eye_distance/ | 1.07077726 |
83 | MP0003191_abnormal_cellular_cholesterol | 1.04053428 |
84 | MP0000685_abnormal_immune_system | 1.03813241 |
85 | MP0001533_abnormal_skeleton_physiology | 1.02427515 |
86 | MP0003091_abnormal_cell_migration | 1.02419490 |
87 | MP0005551_abnormal_eye_electrophysiolog | 1.01520078 |
88 | MP0001790_abnormal_immune_system | 1.00921398 |
89 | MP0005387_immune_system_phenotype | 1.00921398 |
90 | MP0008875_abnormal_xenobiotic_pharmacok | 1.00356813 |
91 | MP0003279_aneurysm | 1.00286637 |
92 | MP0001346_abnormal_lacrimal_gland | 1.00121612 |
93 | MP0002086_abnormal_extraembryonic_tissu | 0.98968955 |
94 | MP0000747_muscle_weakness | 0.98183148 |
95 | MP0009840_abnormal_foam_cell | 0.97795427 |
96 | MP0004808_abnormal_hematopoietic_stem | 0.97509895 |
97 | MP0004264_abnormal_extraembryonic_tissu | 0.97315883 |
98 | MP0004233_abnormal_muscle_weight | 0.97141686 |
99 | MP0001545_abnormal_hematopoietic_system | 0.96720243 |
100 | MP0005397_hematopoietic_system_phenotyp | 0.96720243 |
101 | MP0005167_abnormal_blood-brain_barrier | 0.95781754 |
102 | MP0003283_abnormal_digestive_organ | 0.95054686 |
103 | MP0001849_ear_inflammation | 0.94981063 |
104 | MP0001614_abnormal_blood_vessel | 0.94499396 |
105 | MP0004510_myositis | 0.94449940 |
106 | MP0002166_altered_tumor_susceptibility | 0.91807542 |
107 | MP0001175_abnormal_lung_morphology | 0.91747898 |
108 | MP0000538_abnormal_urinary_bladder | 0.91242273 |
109 | MP0002972_abnormal_cardiac_muscle | 0.90641087 |
110 | MP0005375_adipose_tissue_phenotype | 0.90492082 |
111 | MP0003943_abnormal_hepatobiliary_system | 0.89851502 |
112 | MP0004185_abnormal_adipocyte_glucose | 0.88773007 |
113 | MP0005621_abnormal_cell_physiology | 0.88324534 |
114 | MP0005620_abnormal_muscle_contractility | 0.87601179 |
115 | MP0002089_abnormal_postnatal_growth/wei | 0.87357359 |
116 | MP0002090_abnormal_vision | 0.87071508 |
117 | MP0005083_abnormal_biliary_tract | 0.87031371 |
118 | MP0000249_abnormal_blood_vessel | 0.86431402 |
119 | MP0003656_abnormal_erythrocyte_physiolo | 0.86358477 |
120 | MP0002128_abnormal_blood_circulation | 0.85139778 |
121 | MP0003984_embryonic_growth_retardation | 0.84374862 |
122 | MP0000383_abnormal_hair_follicle | 0.84136163 |
123 | MP0002837_dystrophic_cardiac_calcinosis | 0.83971104 |
124 | MP0006138_congestive_heart_failure | 0.83573589 |
125 | MP0001835_abnormal_antigen_presentation | 0.83500116 |
126 | MP0000733_abnormal_muscle_development | 0.83203352 |
127 | MP0003172_abnormal_lysosome_physiology | 0.83098012 |
128 | MP0002452_abnormal_antigen_presenting | 0.82571876 |
129 | MP0004087_abnormal_muscle_fiber | 0.82292042 |
130 | MP0003075_altered_response_to | 0.82195748 |
131 | MP0002108_abnormal_muscle_morphology | 0.81962108 |
132 | MP0010155_abnormal_intestine_physiology | 0.81649669 |
133 | MP0000678_abnormal_parathyroid_gland | 0.81599716 |
134 | MP0006082_CNS_inflammation | 0.80220985 |
135 | MP0005310_abnormal_salivary_gland | 0.79941902 |
136 | MP0002088_abnormal_embryonic_growth/wei | 0.79563551 |
137 | MP0000566_synostosis | 0.79359343 |
138 | MP0000230_abnormal_systemic_arterial | 0.79095132 |
139 | MP0005330_cardiomyopathy | 0.78999288 |
140 | MP0002254_reproductive_system_inflammat | 0.78961261 |
141 | MP0001485_abnormal_pinna_reflex | 0.77923931 |
142 | MP0005408_hypopigmentation | 0.77820963 |
143 | MP0002928_abnormal_bile_duct | 0.77076848 |
144 | MP0002009_preneoplasia | 0.77004886 |
145 | MP0004215_abnormal_myocardial_fiber | 0.76409410 |
146 | MP0005503_abnormal_tendon_morphology | 0.75874842 |
147 | MP0002420_abnormal_adaptive_immunity | 0.75559297 |
148 | MP0001819_abnormal_immune_cell | 0.75068136 |
149 | MP0000762_abnormal_tongue_morphology | 0.74732344 |
150 | MP0003634_abnormal_glial_cell | 0.74173716 |
151 | MP0002723_abnormal_immune_serum | 0.74054238 |
152 | MP0001800_abnormal_humoral_immune | 0.73953296 |
153 | MP0002006_tumorigenesis | 0.73940420 |
154 | MP0004130_abnormal_muscle_cell | 0.73137018 |
155 | MP0001879_abnormal_lymphatic_vessel | 0.73059796 |
156 | MP0003690_abnormal_glial_cell | 0.72319610 |
157 | MP0003115_abnormal_respiratory_system | 0.70850072 |
158 | MP0004484_altered_response_of | 0.69775362 |
159 | MP0000003_abnormal_adipose_tissue | 0.68802868 |
160 | MP0000604_amyloidosis | 0.67838452 |
161 | MP0000579_abnormal_nail_morphology | 0.67193038 |
162 | MP0002135_abnormal_kidney_morphology | 0.66799183 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperactive renin-angiotensin system (HP:0000841) | 5.70611999 |
2 | Increased circulating renin level (HP:0000848) | 5.33322779 |
3 | Hypokalemic alkalosis (HP:0001949) | 5.25546685 |
4 | Gout (HP:0001997) | 5.20560367 |
5 | Abnormality of chloride homeostasis (HP:0011422) | 4.92834092 |
6 | Metabolic alkalosis (HP:0200114) | 4.85380971 |
7 | Hypomagnesemia (HP:0002917) | 4.53546148 |
8 | Renal salt wasting (HP:0000127) | 4.25735875 |
9 | Abnormality of renal excretion (HP:0011036) | 4.15462362 |
10 | Polyuria (HP:0000103) | 4.03789292 |
11 | Abnormality of the fingertips (HP:0001211) | 3.96773280 |
12 | Abnormal urine output (HP:0012590) | 3.95248836 |
13 | Hyperaldosteronism (HP:0000859) | 3.87449654 |
14 | Abnormality of renin-angiotensin system (HP:0000847) | 3.79644065 |
15 | Abnormality of magnesium homeostasis (HP:0004921) | 3.55415689 |
16 | Interstitial pulmonary disease (HP:0006530) | 3.49989963 |
17 | Increased purine levels (HP:0004368) | 3.47931649 |
18 | Hyperuricemia (HP:0002149) | 3.47931649 |
19 | Eczematoid dermatitis (HP:0000976) | 3.45339603 |
20 | Abnormal drinking behavior (HP:0030082) | 3.42299435 |
21 | Polydipsia (HP:0001959) | 3.42299435 |
22 | Tetany (HP:0001281) | 3.38064628 |
23 | Deep venous thrombosis (HP:0002625) | 3.18925031 |
24 | Proximal tubulopathy (HP:0000114) | 3.11278518 |
25 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.05556776 |
26 | Abnormality of purine metabolism (HP:0004352) | 2.93881876 |
27 | Tubulointerstitial fibrosis (HP:0005576) | 2.90806333 |
28 | Hypercalciuria (HP:0002150) | 2.84409474 |
29 | Broad metatarsal (HP:0001783) | 2.75738778 |
30 | Hypokalemia (HP:0002900) | 2.74820762 |
31 | Abnormality of potassium homeostasis (HP:0011042) | 2.71006102 |
32 | Alkalosis (HP:0001948) | 2.69877657 |
33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.60396190 |
34 | Cardiovascular calcification (HP:0011915) | 2.51947332 |
35 | Potter facies (HP:0002009) | 2.50802263 |
36 | Facial shape deformation (HP:0011334) | 2.50802263 |
37 | Muscle fiber splitting (HP:0003555) | 2.50017166 |
38 | Hyperkalemia (HP:0002153) | 2.48129242 |
39 | Vascular calcification (HP:0004934) | 2.47331273 |
40 | Orchitis (HP:0100796) | 2.45565935 |
41 | Abnormality of macrophages (HP:0004311) | 2.44208057 |
42 | Ketoacidosis (HP:0001993) | 2.42929898 |
43 | Esophageal varix (HP:0002040) | 2.40172288 |
44 | Recurrent abscess formation (HP:0002722) | 2.38710221 |
45 | Flat acetabular roof (HP:0003180) | 2.37434647 |
46 | Hypoplasia of the iris (HP:0007676) | 2.33603859 |
47 | Subacute progressive viral hepatitis (HP:0006572) | 2.33270580 |
48 | Tachypnea (HP:0002789) | 2.31964771 |
49 | Optic neuritis (HP:0100653) | 2.31568356 |
50 | Retrobulbar optic neuritis (HP:0100654) | 2.31568356 |
51 | Thin bony cortex (HP:0002753) | 2.27301135 |
52 | Hyporeflexia of lower limbs (HP:0002600) | 2.22954254 |
53 | Lymphangioma (HP:0100764) | 2.22272738 |
54 | Myositis (HP:0100614) | 2.20867947 |
55 | Hydroxyprolinuria (HP:0003080) | 2.19915892 |
56 | Abnormality of proline metabolism (HP:0010907) | 2.19915892 |
57 | Atrophic scars (HP:0001075) | 2.19418673 |
58 | Glomerulosclerosis (HP:0000096) | 2.17851688 |
59 | Hemorrhage of the eye (HP:0011885) | 2.15851825 |
60 | Adrenal overactivity (HP:0002717) | 2.15592154 |
61 | Gingivitis (HP:0000230) | 2.14900797 |
62 | Prolonged bleeding time (HP:0003010) | 2.14804733 |
63 | Abnormality of the common coagulation pathway (HP:0010990) | 2.14748403 |
64 | Renal tubular acidosis (HP:0001947) | 2.14731508 |
65 | Recurrent bacterial skin infections (HP:0005406) | 2.14480154 |
66 | Spontaneous hematomas (HP:0007420) | 2.14222984 |
67 | Broad face (HP:0000283) | 2.13794821 |
68 | Shallow orbits (HP:0000586) | 2.13373925 |
69 | Visceral angiomatosis (HP:0100761) | 2.12144903 |
70 | Hyperglycinuria (HP:0003108) | 2.12077230 |
71 | Complement deficiency (HP:0004431) | 2.11996592 |
72 | Premature rupture of membranes (HP:0001788) | 2.10792641 |
73 | Menorrhagia (HP:0000132) | 2.08967729 |
74 | Abnormality of complement system (HP:0005339) | 2.08638146 |
75 | Cerebral aneurysm (HP:0004944) | 2.06109341 |
76 | Gingival bleeding (HP:0000225) | 2.05978284 |
77 | Right ventricular cardiomyopathy (HP:0011663) | 2.03462716 |
78 | Obstructive sleep apnea (HP:0002870) | 2.02832733 |
79 | Myocardial infarction (HP:0001658) | 2.02695278 |
80 | Tubular atrophy (HP:0000092) | 2.02122426 |
81 | Increased cerebral lipofuscin (HP:0011813) | 2.02050275 |
82 | Systemic lupus erythematosus (HP:0002725) | 1.97501395 |
83 | Persistence of primary teeth (HP:0006335) | 1.95609229 |
84 | Hemangiomatosis (HP:0007461) | 1.95202396 |
85 | Macroorchidism (HP:0000053) | 1.94974427 |
86 | Dislocated radial head (HP:0003083) | 1.94839474 |
87 | Neurofibrillary tangles (HP:0002185) | 1.94682684 |
88 | Joint hemorrhage (HP:0005261) | 1.94001939 |
89 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93707960 |
90 | Dysmetric saccades (HP:0000641) | 1.93477058 |
91 | Aortic aneurysm (HP:0004942) | 1.93398156 |
92 | Distal upper limb amyotrophy (HP:0007149) | 1.93224187 |
93 | Upper limb amyotrophy (HP:0009129) | 1.93224187 |
94 | Glomerulonephritis (HP:0000099) | 1.93211788 |
95 | Nephrolithiasis (HP:0000787) | 1.89908647 |
96 | Nephrocalcinosis (HP:0000121) | 1.89112885 |
97 | Ulnar bowing (HP:0003031) | 1.87017818 |
98 | Aortic dissection (HP:0002647) | 1.85501911 |
99 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84433721 |
100 | Increased connective tissue (HP:0009025) | 1.83969287 |
101 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.83056234 |
102 | Arterial tortuosity (HP:0005116) | 1.82955828 |
103 | Long eyelashes (HP:0000527) | 1.82924840 |
104 | Turricephaly (HP:0000262) | 1.82719557 |
105 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.82274426 |
106 | Broad palm (HP:0001169) | 1.81687172 |
107 | Vascular tortuosity (HP:0004948) | 1.81577732 |
108 | Focal segmental glomerulosclerosis (HP:0000097) | 1.81395368 |
109 | Epistaxis (HP:0000421) | 1.80231535 |
110 | Long toe (HP:0010511) | 1.79913436 |
111 | Amyloidosis (HP:0011034) | 1.79131384 |
112 | Abnormality of glycine metabolism (HP:0010895) | 1.78791336 |
113 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.78791336 |
114 | Cervical subluxation (HP:0003308) | 1.78457049 |
115 | Dehydration (HP:0001944) | 1.78007114 |
116 | Polycythemia (HP:0001901) | 1.77916505 |
117 | Gastrointestinal infarctions (HP:0005244) | 1.77333560 |
118 | Purpura (HP:0000979) | 1.76801124 |
119 | Abnormality of the thoracic spine (HP:0100711) | 1.76548936 |
120 | Scapular winging (HP:0003691) | 1.76459306 |
121 | Hyperacusis (HP:0010780) | 1.76433426 |
122 | Hand muscle atrophy (HP:0009130) | 1.75964032 |
123 | Germ cell neoplasia (HP:0100728) | 1.75577123 |
124 | Arterial thrombosis (HP:0004420) | 1.75114573 |
125 | Congenital stationary night blindness (HP:0007642) | 1.74562325 |
126 | Metaphyseal cupping (HP:0003021) | 1.74048282 |
127 | Tubulointerstitial abnormality (HP:0001969) | 1.73981410 |
128 | Disproportionate tall stature (HP:0001519) | 1.73632984 |
129 | Ketosis (HP:0001946) | 1.73214855 |
130 | Aplasia of the phalanges of the hand (HP:0009802) | 1.73156438 |
131 | Aplasia involving bones of the extremities (HP:0009825) | 1.73156438 |
132 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.73156438 |
133 | Submucous cleft hard palate (HP:0000176) | 1.72916866 |
134 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.72868321 |
135 | Mitral valve prolapse (HP:0001634) | 1.72719451 |
136 | Abnormality of the radial head (HP:0003995) | 1.72688463 |
137 | Asymmetry of the thorax (HP:0001555) | 1.72350402 |
138 | Cerebral inclusion bodies (HP:0100314) | 1.71702245 |
139 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.71568497 |
140 | Decreased circulating renin level (HP:0003351) | 1.71164508 |
141 | Keratoconjunctivitis sicca (HP:0001097) | 1.70969240 |
142 | Abnormality of the lumbar spine (HP:0100712) | 1.68592619 |
143 | Stridor (HP:0010307) | 1.68464849 |
144 | Vertebral arch anomaly (HP:0008438) | 1.67274891 |
145 | Distal lower limb amyotrophy (HP:0008944) | 1.67137435 |
146 | Abnormality of sodium homeostasis (HP:0010931) | 1.65948935 |
147 | Axonal loss (HP:0003447) | 1.64281862 |
148 | Generalized aminoaciduria (HP:0002909) | 1.63822554 |
149 | Cellulitis (HP:0100658) | 1.63769940 |
150 | Bronchomalacia (HP:0002780) | 1.61344473 |
151 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.61272729 |
152 | Loss of speech (HP:0002371) | 1.61191841 |
153 | Advanced eruption of teeth (HP:0006288) | 1.60904554 |
154 | Aneurysm (HP:0002617) | 1.60253515 |
155 | Knee flexion contracture (HP:0006380) | 1.59799161 |
156 | Pathologic fracture (HP:0002756) | 1.58501262 |
157 | Mitral stenosis (HP:0001718) | 1.58321566 |
158 | Buphthalmos (HP:0000557) | 1.58197859 |
159 | Osteolytic defects of the hand bones (HP:0009699) | 1.57625037 |
160 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.57625037 |
161 | Ventricular tachycardia (HP:0004756) | 1.57563438 |
162 | Rickets (HP:0002748) | 1.57256163 |
163 | Skull defect (HP:0001362) | 1.57234052 |
164 | Onion bulb formation (HP:0003383) | 1.57075520 |
165 | Chondrocalcinosis (HP:0000934) | 1.56944972 |
166 | Ankyloglossia (HP:0010296) | 1.56837862 |
167 | Abnormality of the peritoneum (HP:0002585) | 1.56646705 |
168 | Thoracic kyphosis (HP:0002942) | 1.56432784 |
169 | Craniofacial hyperostosis (HP:0004493) | 1.56331219 |
170 | Keratoconjunctivitis (HP:0001096) | 1.56275831 |
171 | Central scotoma (HP:0000603) | 1.55738046 |
172 | Abnormality of incisor morphology (HP:0011063) | 1.55509915 |
173 | Hypotension (HP:0002615) | 1.54735736 |
174 | Viral hepatitis (HP:0006562) | 1.53971559 |
175 | Abnormality of the nasal septum (HP:0000419) | 1.53462215 |
176 | Pulmonary embolism (HP:0002204) | 1.53009571 |
177 | Colitis (HP:0002583) | 1.52706935 |
178 | Recurrent skin infections (HP:0001581) | 1.52400265 |
179 | Increased IgE level (HP:0003212) | 1.51710463 |
180 | Narrow palate (HP:0000189) | 1.51405409 |
181 | Acne (HP:0001061) | 1.51064527 |
182 | Mucopolysacchariduria (HP:0008155) | 1.50998111 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK4 | 5.26107265 |
2 | STK39 | 3.99934230 |
3 | OXSR1 | 3.92383520 |
4 | CDK12 | 3.47761488 |
5 | WNK3 | 3.18494404 |
6 | EPHB1 | 3.13478096 |
7 | PRPF4B | 2.65901327 |
8 | RIPK4 | 2.26198581 |
9 | LATS1 | 2.20812403 |
10 | TRIB3 | 2.13052868 |
11 | WNK1 | 2.11959862 |
12 | RIPK1 | 2.05309291 |
13 | EEF2K | 2.03190120 |
14 | TTN | 2.02090458 |
15 | FGFR2 | 2.00580215 |
16 | DDR2 | 1.80879613 |
17 | BLK | 1.78730700 |
18 | LMTK2 | 1.75898602 |
19 | MAP3K13 | 1.75386576 |
20 | MAP2K3 | 1.75069391 |
21 | FER | 1.69655052 |
22 | SMG1 | 1.59403506 |
23 | STK38L | 1.48284669 |
24 | MST1R | 1.47288013 |
25 | CSK | 1.46999394 |
26 | PTK6 | 1.44095524 |
27 | EPHA3 | 1.42536200 |
28 | ZAP70 | 1.40392667 |
29 | LRRK2 | 1.39090669 |
30 | STK38 | 1.38824743 |
31 | MET | 1.37771525 |
32 | PDGFRA | 1.36619293 |
33 | TYK2 | 1.36014852 |
34 | PTK2 | 1.34136563 |
35 | SIK1 | 1.31150251 |
36 | CAMK1G | 1.27116680 |
37 | FGFR4 | 1.26414799 |
38 | SGK223 | 1.25505560 |
39 | SGK494 | 1.25505560 |
40 | PAK3 | 1.20594777 |
41 | FGR | 1.19140514 |
42 | MAP3K6 | 1.16342575 |
43 | MAP3K2 | 1.16202715 |
44 | NTRK1 | 1.13586724 |
45 | MAP3K14 | 1.12860058 |
46 | BMX | 1.12828182 |
47 | DMPK | 1.11872792 |
48 | YES1 | 1.10965215 |
49 | MAP3K1 | 1.09376092 |
50 | BRD4 | 1.08436061 |
51 | FES | 1.08147608 |
52 | PKN2 | 1.07132467 |
53 | MAP3K7 | 1.03396650 |
54 | TIE1 | 1.01989183 |
55 | PDGFRB | 0.99916536 |
56 | PDK3 | 0.97887964 |
57 | PDK4 | 0.97887964 |
58 | CAMK1D | 0.96665691 |
59 | MAP4K1 | 0.95886073 |
60 | MAP3K10 | 0.95118497 |
61 | TGFBR2 | 0.94751445 |
62 | PDK2 | 0.89973827 |
63 | PAK4 | 0.89267310 |
64 | SGK3 | 0.87588598 |
65 | RET | 0.87567468 |
66 | CSF1R | 0.87332250 |
67 | EPHA2 | 0.87170369 |
68 | EPHB2 | 0.86295416 |
69 | MYLK | 0.85309539 |
70 | RPS6KA2 | 0.85256475 |
71 | ERN1 | 0.85060059 |
72 | GSK3A | 0.84469273 |
73 | AKT3 | 0.83761443 |
74 | PAK6 | 0.82322733 |
75 | NLK | 0.82138200 |
76 | PHKG1 | 0.81797238 |
77 | PHKG2 | 0.81797238 |
78 | BCKDK | 0.81567733 |
79 | IRAK4 | 0.81161933 |
80 | MST4 | 0.80927550 |
81 | IRAK1 | 0.80718775 |
82 | PRKD1 | 0.79713900 |
83 | PRKD3 | 0.76456715 |
84 | ROCK2 | 0.75809589 |
85 | TRPM7 | 0.75333631 |
86 | PDK1 | 0.74016337 |
87 | KSR2 | 0.72890449 |
88 | MELK | 0.72693610 |
89 | FGFR1 | 0.71440801 |
90 | ROCK1 | 0.71329326 |
91 | PTK2B | 0.69687290 |
92 | MAPK7 | 0.69238513 |
93 | MAPK12 | 0.68795608 |
94 | LATS2 | 0.67129233 |
95 | HCK | 0.66886003 |
96 | PDPK1 | 0.66714705 |
97 | JAK2 | 0.65021683 |
98 | FGFR3 | 0.63928764 |
99 | PRKCH | 0.62580325 |
100 | SIK2 | 0.61983555 |
101 | TYRO3 | 0.60565625 |
102 | RPS6KC1 | 0.60146451 |
103 | RPS6KL1 | 0.60146451 |
104 | JAK3 | 0.59114629 |
105 | MTOR | 0.59069236 |
106 | STK3 | 0.58997199 |
107 | INSRR | 0.58456267 |
108 | MAPK11 | 0.58302139 |
109 | CDK6 | 0.57186063 |
110 | CDC42BPA | 0.56826841 |
111 | ERBB2 | 0.56336091 |
112 | NEK1 | 0.55964923 |
113 | STK10 | 0.55284215 |
114 | BTK | 0.54349394 |
115 | CAMK4 | 0.54180373 |
116 | IRAK3 | 0.53471720 |
117 | FRK | 0.52560276 |
118 | SGK1 | 0.52352275 |
119 | PAK2 | 0.51633504 |
120 | SGK2 | 0.51321322 |
121 | PRKD2 | 0.51035397 |
122 | JAK1 | 0.51015468 |
123 | ICK | 0.50389686 |
124 | MARK2 | 0.49824640 |
125 | PRKAA2 | 0.49815650 |
126 | MATK | 0.49497672 |
127 | MAP3K9 | 0.48971432 |
128 | PINK1 | 0.48720946 |
129 | PIK3CA | 0.47394172 |
130 | PRKAA1 | 0.46425537 |
131 | DYRK1B | 0.45552202 |
132 | HIPK2 | 0.43909041 |
133 | DAPK2 | 0.43499557 |
134 | RPS6KA6 | 0.42592585 |
135 | PKN1 | 0.41395602 |
136 | PRKCE | 0.37972157 |
137 | STK24 | 0.36986641 |
138 | SRC | 0.36068742 |
139 | NEK9 | 0.35158928 |
140 | MAP3K3 | 0.34361453 |
141 | INSR | 0.34147963 |
142 | CAMK2D | 0.33139821 |
143 | LIMK1 | 0.32651379 |
144 | FYN | 0.32076981 |
145 | ILK | 0.31047958 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.89883596 |
2 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.18227417 |
3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.16069671 |
4 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.11418064 |
5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87494404 |
6 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.85750218 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.82934802 |
8 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.81742556 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.79129333 |
10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73296064 |
11 | Mineral absorption_Homo sapiens_hsa04978 | 1.70554227 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.67220965 |
13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62669176 |
14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.59724475 |
15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.59699048 |
16 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.59145386 |
17 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.57188939 |
18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.55312982 |
19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.53549194 |
20 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.51158939 |
21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.50835038 |
22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49877618 |
23 | Bile secretion_Homo sapiens_hsa04976 | 1.49625409 |
24 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.47635946 |
25 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.43279940 |
26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43211013 |
27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.41553685 |
28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38855794 |
29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34846472 |
30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.33365367 |
31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26969043 |
32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.24980955 |
33 | Platelet activation_Homo sapiens_hsa04611 | 1.24510756 |
34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.23552155 |
35 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.22996469 |
36 | Lysosome_Homo sapiens_hsa04142 | 1.22591005 |
37 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.20949973 |
38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20868821 |
39 | Thyroid cancer_Homo sapiens_hsa05216 | 1.20627934 |
40 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.18129606 |
41 | Focal adhesion_Homo sapiens_hsa04510 | 1.17304772 |
42 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.16401719 |
43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.15297362 |
44 | Peroxisome_Homo sapiens_hsa04146 | 1.14311794 |
45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13914723 |
46 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.13610947 |
47 | Lysine degradation_Homo sapiens_hsa00310 | 1.13579506 |
48 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.12448553 |
49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.09511625 |
50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09199433 |
51 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.08747491 |
52 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.07836303 |
53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.06514223 |
54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02624012 |
55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01863436 |
56 | Tight junction_Homo sapiens_hsa04530 | 1.00848676 |
57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00214321 |
58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.99806239 |
59 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.99507875 |
60 | Prostate cancer_Homo sapiens_hsa05215 | 0.98483907 |
61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98381050 |
62 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.98308051 |
63 | Hepatitis C_Homo sapiens_hsa05160 | 0.95910085 |
64 | Adherens junction_Homo sapiens_hsa04520 | 0.94705956 |
65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94650714 |
66 | Pertussis_Homo sapiens_hsa05133 | 0.94576376 |
67 | Malaria_Homo sapiens_hsa05144 | 0.94551816 |
68 | Tuberculosis_Homo sapiens_hsa05152 | 0.94045218 |
69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93570522 |
70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91937499 |
71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91400207 |
72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91126259 |
73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90417401 |
74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.88063464 |
75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.87797881 |
76 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.86549080 |
77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85214509 |
78 | Influenza A_Homo sapiens_hsa05164 | 0.84646369 |
79 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.84343827 |
80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83835956 |
81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83298588 |
82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82871465 |
83 | Hepatitis B_Homo sapiens_hsa05161 | 0.80955807 |
84 | Amoebiasis_Homo sapiens_hsa05146 | 0.80652927 |
85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.80275464 |
86 | Prion diseases_Homo sapiens_hsa05020 | 0.79591690 |
87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.79220412 |
88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.78854944 |
89 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78222777 |
90 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77995813 |
91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77922441 |
92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76712680 |
93 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76590045 |
94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74985680 |
95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74742681 |
96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.73372704 |
97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71800094 |
98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71026816 |
99 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70600145 |
100 | Salivary secretion_Homo sapiens_hsa04970 | 0.70267807 |
101 | Phototransduction_Homo sapiens_hsa04744 | 0.70242997 |
102 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.70017987 |
103 | Measles_Homo sapiens_hsa05162 | 0.68436989 |
104 | Insulin resistance_Homo sapiens_hsa04931 | 0.67497211 |
105 | Apoptosis_Homo sapiens_hsa04210 | 0.67385124 |
106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67356142 |
107 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.66435314 |
108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66270191 |
109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.66263024 |
110 | Carbon metabolism_Homo sapiens_hsa01200 | 0.65526247 |
111 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65224323 |
112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64702394 |
113 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64694315 |
114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63433435 |
115 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.63123220 |
116 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63022460 |
117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.62397293 |
118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62071203 |
119 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61581073 |
120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61518197 |
121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61355001 |
122 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60599405 |
123 | Renin secretion_Homo sapiens_hsa04924 | 0.60037932 |
124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59664749 |
125 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57577681 |
126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57191603 |
127 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56996801 |
128 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56663766 |
129 | Phagosome_Homo sapiens_hsa04145 | 0.56204247 |
130 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55781902 |
131 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.55561243 |
132 | Bladder cancer_Homo sapiens_hsa05219 | 0.53798040 |
133 | Axon guidance_Homo sapiens_hsa04360 | 0.53769284 |
134 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53519405 |
135 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53265075 |
136 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52681452 |
137 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52558509 |
138 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52378377 |
139 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52356992 |
140 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51679766 |
141 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.50970319 |
142 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50344691 |
143 | Legionellosis_Homo sapiens_hsa05134 | 0.49575760 |
144 | ABC transporters_Homo sapiens_hsa02010 | 0.49405750 |
145 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49334285 |
146 | Endocytosis_Homo sapiens_hsa04144 | 0.48338844 |
147 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47088668 |
148 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46897943 |
149 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.46791894 |
150 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46538036 |
151 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44582656 |
152 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.42523058 |
153 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41625230 |
154 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41498923 |
155 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40844672 |
156 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40220067 |
157 | Glioma_Homo sapiens_hsa05214 | 0.40139965 |
158 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40139365 |
159 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39847810 |
160 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.39474176 |